Onkologie. 2013:7(2):74-77

Fluorescence in situ hybridization in diagnostics melanocytic lesions

Jana Dvořáčková1,2,3, Jana Žmolíková1,2, Jan Mužík4, Magdalena Uvírová1,2
1 Lékařská fakulta Ostravské univerzity v Ostravě
2 CGB laboratoř a.s., Ostrava
3 Ústav patologie FN Ostrava
4 Institut biostatistiky a analýz, Masarykova univerzita, Brno

Melanocytic lesions exhibit significant morphological heterogenity, making their diagnosis difficult, although both sophisticated histopathological

and immunohistochemical methods are used. The introduction of molecular genetic method flourescence in situ hybridization

(FISH) has contributed significantly to the diagnosing of melanocytic lesions. Between 2008 and 2012, we studied a total of 160 samples

of different types of melanocytic lesions, including 44 nevi and 116 melanomas, using a four-color probe mix for CCND1, RREB1 and MYB

genes and for the centromere of chromosome 6. A positive result was found in 116 melenoma samples (72.5 %) and a negative result in

41 samples (25.6 %). A borderline value was found in two samples (1.2 %), and an atypical finding (monosomy of chromosome 6) was seen

in a melanoma recurrence in one case (0.6 %). Sensitivity and specificity were 96.6 % and 91 %, respectively. These results show that FISH

is a suitable and relatively low-cost method for accurate, rapid diagnosis of ambiguous melanocytic lesions. The speed and accuracy

of diagnosis of highly malignant melanomas are crucial and have great impact on the prognosis and success of a patient‘s treatment.

Keywords: melanoma, naevus, fluorescence in situ hybridization, FISH, gene

Published: May 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dvořáčková J, Žmolíková J, Mužík J, Uvírová M. Fluorescence in situ hybridization in diagnostics melanocytic lesions. Onkologie. 2013;7(2):74-77.
Download citation

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008; 58: 71-96. Go to original source... Go to PubMed...
  2. American Cancer Society. A Cyncer Journal for Clinicians, Global Cancer Statistic 02. Atlanta: American Cancer Society 2006.
  3. Veenhuizen KCW, De Wit PEJD, Mooi WJ, Scheffer E, Verbeek ALM, Ruiter DJ. Quality assessment by expert opinion in melanoma pathology: experience of the Pathology Panel of the Dutch Melanoma Working Party, The Journal of Pathology 1997; 182: 266-272. Go to original source... Go to PubMed...
  4. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying Melanocytic Tumours Based on DNA Copy Number Changes. The American Journal of Pathology. 2006; 163: 1765-1770. Go to original source... Go to PubMed...
  5. Dahlstrom JE, Scolyer RA, Thompson JF, Jain S. Spitz naevus: diagnostic problems and their management implications. Pathology 2004; 36 (5): 452-457. Go to original source... Go to PubMed...
  6. Bastian BC, LeBoit PE, Hamm H., Brocker EB, and Pinkel D. Chromosomal gains and loses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Research 1998; 58: 2170-2175. Go to original source... Go to PubMed...
  7. Bastien BC. Uderstanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 2003; 22: 3081-3086. Go to original source... Go to PubMed...
  8. Su Luo, Alireza Sepehr, Hensin Tsao: Spitz nevi and other Spitzoid lesions: Part I. Background and diagnoses. Journal of the American Academy of Dermatology 2011; 65: 1073-1084. Go to original source... Go to PubMed...
  9. Bastien BC, Wesselmann U, Pinkel D and LeBoit PE. Molecular cytogenetic analysis of Spitz nevi with distinctive histopatologic features. The American Journal of Pathology 2000; 157: 967-972. Go to original source... Go to PubMed...
  10. Bastien BC, Wasselmann U, Pinkel D, LeBoit PE. Molecular Cytogenetic Analysis of Spitz Nevi Shows Clear Differences to Melanoma. The Journal of Investigative Dermatology 1999; 133 (6), 1065-1069. Go to original source... Go to PubMed...
  11. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. The American Journal of Surgical Pathology 2009; 33: 1146-1156. Go to original source... Go to PubMed...
  12. Gaiser T, Kutzner H, Palmedo G., et al. Classifying ambiguous melanocytic lesions with FISH and correlation with long-term follow up. Modern Pathology 2010; 23, 413-419. Go to original source... Go to PubMed...
  13. Moore MW and Gasparini R. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions. Diagnostic Pathology 2011; 6: 76. Go to original source... Go to PubMed...
  14. Gerami P, Zembowitz A: Update on Fluorescence In Situ Hybridization in Melanoma. Archives of Pathology & Laboratory Medicine 2011; 135: 830-837. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.